Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics was planning to go public, but the IPO was withdrawn on Feb 21, 2025.

IPO Price

$6.25

Shares Offered

2,480,000

Deal Size

$15.50M

Felicitex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	45	-	-
Enterprise Value	45	-	-
Debt / Equity Ratio	-0.29	-0.32	-0.70
Debt / EBITDA Ratio	-0.14	-0.19	-0.97
Debt / FCF Ratio	-0.22	-0.29	-0.54
Net Debt / Equity Ratio	-0.25	-0.31	-0.64
Net Debt / EBITDA Ratio	-0.12	-0.18	-0.90
Net Debt / FCF Ratio	-0.19	-0.28	-0.50
Quick Ratio	0.03	0.01	0.05
Interest Coverage	-185.74	-	-17.36
Return on Equity (ROE)	202.60%	169.85%	94.71%
Return on Assets (ROA)	-	-8541.99%	-1534.91%
Return on Capital Employed (ROCE)	190.87%	170.59%	89.55%